Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Sanofi
Company Monitoring Page for Sanofi
latest headlines for company on cafepharma
Sanofi Aims To Be Pharma’s Top R&D Organization, Zerhouni Says
Bloomberg
Thu, 05/31/12 - 06:17 pm
Tags:
R&D
,
Sanofi
New Drug Could Be Game Changer For Sanofi
Seeking Alpha
Thu, 05/31/12 - 06:11 pm
Tags:
Sanofi
,
liver cancer
,
GSK
,
AstraZeneca
,
Bristol-Myers Squibb
New Drug Could Push AstraZeneca 20% Higher
Seeking Alpha
Thu, 05/31/12 - 09:38 am
Tags:
AstraZeneca
,
JNJ
,
Bristol-Myers Squibb
,
Eli Lilly
,
Pfizer
,
Sanofi
,
GSK
With Plavix gone generic, payers aim to cut Effient, Brilinta
Fierce Pharma
Wed, 05/30/12 - 11:30 am
Tags:
generics
,
Effient
,
Plavix
,
Brilinta
,
Eli Lilly
,
bloodthinners
,
AstraZeneca
,
Sanofi
,
Bristol-Myers Squibb
Sanofi, Novo, Lilly shape up for big insulin fight
Reuters
Wed, 05/30/12 - 10:25 am
Tags:
Sanofi
,
Novo Nordisk
,
Eli Lilly
,
diabetes
,
insulin
,
Lantus
Bulls Buy Zalicus As Novartis Collaboration Gains Traction
Seeking Alpha
Wed, 05/30/12 - 10:19 am
Tags:
Zalicus
,
Novartis
,
Sanofi
Who Should Buy Amylin?
Motley Fool
Tue, 05/29/12 - 04:44 pm
Tags:
M&A
,
Amylin
,
Sanofi
,
Merck
,
Bristol-Myers Squibb
,
Takeda
,
AstraZeneca
Abbott Labs: Learn From Grace Groner
Seeking Alpha
Tue, 05/29/12 - 11:10 am
Tags:
Abbott Laboratories
,
GSK
,
Merck
,
Pfizer
,
Novartis
,
Sanofi
Reports: Sanofi, Merck Bid At Least $25 Per Share For Amylin
Barron's
Mon, 05/28/12 - 11:11 am
Tags:
Merck
,
Sanofi
,
Amylin
,
M&A
Report Card: Johnson & Johnson And Selected Peers
Seeking Alpha
Wed, 05/23/12 - 11:47 am
Tags:
JNJ
,
Abbott Laboratories
,
Bristol-Myers Squibb
,
Merck
,
Pfizer
,
Sanofi
Bristol-Myers Squibb's Thud Heard Round the World
Motley Fool
Mon, 05/21/12 - 12:19 pm
Tags:
Bristol-Myers Squibb
,
Plavix
,
bloodthinners
,
Sanofi
,
Dr Reddy's
,
generics
,
Sun Pharma
Plavix’s Loss Means Little Gain by Competing Blood Thinners
Bloomberg
Thu, 05/17/12 - 10:26 am
Tags:
Plavix
,
bloodthinners
,
patents
,
Sanofi
,
Bristol-Myers Squibb
,
AstraZeneca
,
Eli Lilly
Plavix Set to Lose Patent Protection
NY Times, NY
Wed, 05/16/12 - 01:37 pm
Tags:
patents
,
Plavix
,
Bristol-Myers Squibb
,
Sanofi
Timing Is Right For Pfizer
Seeking Alpha
Wed, 05/16/12 - 12:22 pm
Tags:
Pfizer
,
generics
,
Novartis
,
Sanofi
,
Eli Lilly
,
GSK
,
Human Genome Sciences
Amylin Goes A Little Wizard Of Oz On Shareholders
Seeking Alpha
Wed, 05/16/12 - 10:58 am
Tags:
Amylin
,
AstraZeneca
,
Bristol-Myers Squibb
,
Pfizer
,
Sanofi
,
Novo Nordisk
,
M&A
Amylin climbs after report says seven companies involved in sales process
Yahoo/Fly on the Wall
Tue, 05/15/12 - 11:57 am
Tags:
Amylin
,
Pfizer
,
AstraZeneca
,
Sanofi
,
Merck
,
Takeda
,
Roche
,
Bristol-Myers Squibb
,
M&A
Why Johnson & Johnson Looks Better Than Its Competitors
Seeking Alpha
Mon, 05/14/12 - 10:19 am
Tags:
JNJ
,
Human Genome Sciences
,
Pfizer
,
Sanofi
,
Edwards Lifesciences
,
GSK
,
AstraZeneca
4 New Reasons To Be Bullish On Sanofi Now
Seeking Alpha
Sun, 05/13/12 - 01:26 pm
Tags:
Sanofi
Sanofi Beats Analyst Estimates on EPS
Motley Fool
Sat, 05/12/12 - 11:52 am
Tags:
Sanofi
,
earnings
Can Teva Win With The Big Pharma Playbook?
Seeking Alpha
Thu, 05/10/12 - 10:56 am
Tags:
Teva Pharmaceuticals
,
Biogen Idec
,
Novartis
,
Sanofi
,
Endo
,
Abbott Laboratories
Pages
« first
‹ previous
…
104
105
106
107
108
109
110
111
112
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.